» Articles » PMID: 33920534

New Insights into Pathomechanisms and Treatment Possibilities for Lung Silicosis

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2021 Apr 30
PMID 33920534
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Inhalation of silica particles is an environmental and occupational cause of silicosis, a type of pneumoconiosis. Development of the lung silicosis is a unique process in which the vicious cycle of ingestion of inhaled silica particles by alveolar macrophages and their release triggers inflammation, generation of nodular lesions, and irreversible fibrosis. The pathophysiology of silicosis is complex, and interactions between the pathomechanisms have not been completely understood. However, elucidation of silica-induced inflammation cascades and inflammation-fibrosis relations has uncovered several novel possibilities of therapeutic targeting. This article reviews new information on the pathophysiology of silicosis and points out several promising treatment approaches targeting silicosis-related pathways.

Citing Articles

Silicosis Incidence and Mortality after Occupational Exposure with Silica Dust: A Systematic Review and Dose-Response Meta-Analysis.

Shahbazi F, Assari M, Shadi Y, Fattahi-Darghlou M Med J Islam Repub Iran. 2025; 38:135.

PMID: 39968475 PMC: 11835395. DOI: 10.47176/mjiri.38.135.


Potential Health Impacts, Treatments, and Countermeasures of Martian Dust on Future Human Space Exploration.

Wang J, Rosenbaum J, Prasad A, Raad R, Putman E, Harrington A Geohealth. 2025; 9(2):e2024GH001213.

PMID: 39944899 PMC: 11815326. DOI: 10.1029/2024GH001213.


Silicosis: from pathogenesis to therapeutics.

Yang B, Liu X, Peng C, Meng X, Jia Q Front Pharmacol. 2025; 16:1516200.

PMID: 39944632 PMC: 11813918. DOI: 10.3389/fphar.2025.1516200.


Development of a multi-laboratory integrated predictive model for silicosis utilizing machine learning: a retrospective case-control study.

Sun G, Xiang Y, Wang L, Xiang P, Wang Z, Zhang J Front Public Health. 2025; 12:1450439.

PMID: 39882130 PMC: 11774866. DOI: 10.3389/fpubh.2024.1450439.


Prevalence and determinants of restrictive lung disorder among quarry workers at the Umuoghara quarry site, Ebonyi State, Nigeria: a cross-sectional study.

Ike-Samuel N, Ekwueme O, Udeh S BMC Pulm Med. 2025; 25(1):22.

PMID: 39819422 PMC: 11736936. DOI: 10.1186/s12890-025-03497-0.


References
1.
Yamada M, Kuwano K, Maeyama T, Yoshimi M, Hamada N, Fukumoto J . Gene transfer of soluble transforming growth factor type II receptor by in vivo electroporation attenuates lung injury and fibrosis. J Clin Pathol. 2006; 60(8):916-20. PMC: 1994490. DOI: 10.1136/jcp.2006.039396. View

2.
Rojas-Quintero J, Wang X, Owen C . Dusting Off IL-9 as a New Therapeutic Target for Pulmonary Fibrosis. Am J Respir Cell Mol Biol. 2018; 60(2):141-143. PMC: 6376410. DOI: 10.1165/rcmb.2018-0319ED. View

3.
Xu T, Yan W, Wu Q, Xu Q, Yuan J, Li Y . MiR-326 Inhibits Inflammation and Promotes Autophagy in Silica-Induced Pulmonary Fibrosis through Targeting TNFSF14 and PTBP1. Chem Res Toxicol. 2019; 32(11):2192-2203. DOI: 10.1021/acs.chemrestox.9b00194. View

4.
Hoffman H, Wanderer A . Inflammasome and IL-1beta-mediated disorders. Curr Allergy Asthma Rep. 2010; 10(4):229-35. PMC: 2892083. DOI: 10.1007/s11882-010-0109-z. View

5.
Barnes H, Goh N, Leong T, Hoy R . Silica-associated lung disease: An old-world exposure in modern industries. Respirology. 2019; 24(12):1165-1175. DOI: 10.1111/resp.13695. View